Titre:
  • Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Auteur:Kenemans, Peter; Bundred, Nigel J; Foidart, Jean-Michel; Kubista, Ernst; von Schoultz, Bo; Sismondi, Piero; Vassilopoulou-Sellin, Rena; Yip, Cheng Har; Egberts, Jan; Mol-Arts, Mirjam; Mulder, Roel; van Os, Bertil; Beckmann, Matthias W; Simon, Philippe
Informations sur la publication:Lancet oncology, 10, 2, page (135-146)
Statut de publication:Publié, 2009-02
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antineoplastic Agents, Hormonal -- adverse effects
Breast Neoplasms -- chemically induced -- pathology
Double-Blind Method
Estrogen Replacement Therapy -- adverse effects
Female
Hot Flashes -- drug therapy
Humans
Middle Aged
Neoplasm Recurrence, Local -- chemically induced -- pathology
Norpregnenes -- adverse effects
Osteoporosis, Postmenopausal -- prevention & control
Vasomotor System -- drug effects
Note générale:Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(08)70341-3
info:pii/S1470-2045(08)70341-3
info:pmid/19167925